Thesis Abstract
Lung cancer is a one of the most cancer types spreaded worldwide. In Egypt, lung cancer counted as the third cause of deaths among males after liver and bladder cancers. Lung cancer characterized with two type's SCLC represents about (10% to 15%) and NSCLCs which represents (80% to 85%). In NSCLCs, treatment only treat15%–30% of patients due to the presence of tumor mediators which enhance tumor surveillance by secreting PGE2, TGF-β. CD8+ and NK are the main cells to defeat and kill cancer cells. The aim of this study is to address the functionality of T-cells and NK cells on lung cancer patient's pre and post stimulation in-vitro.
Lung cancer is a one of the most cancer types spreaded worldwide. In Egypt, lung cancer counted as the third cause of deaths among males after liver and bladder cancers. Lung cancer characterized with two type's SCLC represents about (10% to 15%) and NSCLCs which represents (80% to 85%). In NSCLCs, treatment only treat15%–30% of patients due to the presence of tumor mediators which enhance tumor surveillance by secreting PGE2, TGF-β. CD8+ and NK are the main cells to defeat and kill cancer cells. The aim of this study is to address the functionality of T-cells and NK cells on lung cancer patient's pre and post stimulation in-vitro.
Materials and methods